Latest news with #MarkelGroupInc
Cision Canada
13-05-2025
- Business
- Cision Canada
Markel launches first-of-its-kind affirmative cyber product for collateral war cover
LONDON, May 13, 2025 /CNW/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE:MKL), today launched an innovative, specialist cyber product to provide up to US$5 million of cover per risk for indirect losses arising from an act of war. Cyber risks are a significant concern for large organisations, particularly those in sectors including critical infrastructure, technology, finance and energy. Although full-scale cyber warfare events remain relatively rare, state-sponsored and geopolitically motivated cyber threats continue to increase in frequency and severity 1. State-sponsored cyber-attacks accounted for 35% of all breaches in 2024 2, with multinationals often being the targets or suffering collateral damage. The new product, developed by Markel International's London-based cyber team, provides cyber cover for collateral damage caused by acts of war, in other words losses arising from the indirect impact on an Insured from a war (whether declared or not). Cover for this peril is typically excluded in cyber insurance policies. The new solution has been developed as a wrap-around product for large corporate clients with existing (Markel or non-Markel) cyber insurance policies. If the insured's existing policy is less restrictive on war (such as Type 4 war exclusions) and this is now moving to a more restrictive war exclusion that is not to the client's preference, then this Markel product could provide the insured with an option to insure some or all of that lost coverage. Markel has ring-fenced a fixed amount of aggregate limit for this specific product, which it will be offering under its own name, using its own legal and financial backing. It will initially be offering a limit of up to US$5 million per risk. Chris Burgess, Director of Cyber at Markel International, commented: "With this new product, Markel is responding to the changing needs of our clients. We're conscious that some larger clients still want cyber cover for the indirect impact of war, and this product is a step toward helping provide them with a priced-for insurance policy that explicitly covers this particular risk. "While we're initially beginning with a low limit, today's announcement is a step in the right direction towards providing a market-wide solution for these highly prevalent risks. We hope that providing clients with this cover will help give them the confidence and assurance that their needs are being heard and responded to." 1 World Economic Forum. Global Cybersecurity Outlook 2025 report. January 2025 2 Bright Defense. Latest Cybercrime Statistics 2025. April 2025. About Markel Insurance We are Markel Insurance, a leading global specialty insurer with a truly people-first approach. As the insurance operations within the Markel Group Inc. (NYSE: MKL), we leverage a broad array of capabilities and expertise to create intelligent solutions for the most complex specialty insurance needs. However, it is our people – and the deep, valued relationships they develop with colleagues, brokers and clients – that differentiates us worldwide.
Cision Canada
07-05-2025
- Business
- Cision Canada
Markel Group announces redemption of Series A Preferred Shares
RICHMOND, Va., May 7, 2025 /CNW/ -- Markel Group Inc. (NYSE: MKL) will redeem for cash all of its outstanding Series A 6.000% Fixed-Rate Reset Non-Cumulative Preferred Shares, no par value (the Series A Preferred Shares), effective June 1, 2025 (the Redemption Date) at a price of $1,000 per share, which is equal to the per-share liquidation preference of the Series A Preferred Shares. Since the Redemption Date is not a business day, the redemption will be processed on June 2, 2025. There are currently 600,000 Series A Preferred Shares outstanding with an aggregate liquidation preference of $600.0 million. A regular, semi-annual dividend on the Series A Preferred Shares of $30.00 per share with a dividend payment date of June 1, 2025 will be paid separately, without adjustment, on the next succeeding business day, June 2, 2025, to holders of record as of the close of business on May 17, 2025. Accordingly, the redemption price for the Series A Preferred Shares does not include any accrued and unpaid dividends. The transfer agent and redemption agent for the Series A Preferred Shares is: Equiniti Trust Company, LLC Attn: Reorganization Department 55 Challenger Road, Suite 200 Ridgefield Park, New Jersey 07660 Phone: 718-921-8317 This press release does not constitute a notice of redemption. Markel Group will issue a notice of redemption to holders of the Series A Preferred Shares in accordance with the terms of the Series A Preferred Shares. About Markel Group Markel Group Inc. (NYSE: MKL) is a diverse family of companies that includes everything from insurance to bakery equipment, building supplies, houseplants, and more. The leadership teams of these businesses operate with a high degree of independence, while at the same time living the values that we call the Markel Style. Our specialty insurance business sits at the core of our company. Through decades of sound underwriting, the insurance team has provided the capital base from which we built a system of businesses and investments that collectively increase Markel Group's durability and adaptability. It's a system that provides diverse income streams, access to a wide range of investment opportunities, and the ability to efficiently move capital to the best ideas across the company. Most importantly though, this system enables each of our businesses to advance our shared goal of helping our customers, associates, and shareholders win over the long term. Visit to learn more. Forward-Looking Statements This release contains certain forward-looking statements that are subject to a variety of factors that could cause actual events or results to materially differ from those included in these statements. These factors include the timely availability of funds for the redemption and dividend payment, as well as the factors identified in Markel Group's most recent Form 10-K and Form 10-Q filed with the U.S. Securities and Exchange Commission. Markel Group refers readers to those discussions for further information. Any forward-looking statement speaks only as of the date on which it is made, and Markel Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date on which it is made.
Yahoo
07-05-2025
- Business
- Yahoo
Markel Group Inc. (MKL): A Bull Case Theory
We came across a bullish thesis on Markel Group Inc. (MKL) on Substack by Value Don't Lie. In this article, we will summarize the bulls' thesis on MKL. Markel Group Inc. (MKL)'s share was trading at $1813.28 as of April 28th. MKL's trailing and forward P/E were 9.10 and 12.71 respectively according to Yahoo Finance. Is Progressive Corporation (PGR) the Best Low Volatility Stock to Buy Now? A team of accountants in a boardroom, discussing strategic moves of an insurance company. Markel Corporation, often dubbed a 'mini-Berkshire,' is a diversified insurance holding company with three main segments: specialty insurance, public and private investments, and a collection of non-insurance operating businesses called Markel Ventures. Its core insurance business focuses on long-tail excess and surplus lines, consistently generating underwriting profits in 8 of the last 9 years, though it has lagged peers in recent profitability improvements—especially in reinsurance. Markel Ventures, a $5.1 billion revenue operation with a 12.5% EBITDA margin, spans industries from construction services to consumer products and now contributes 40–50% of consolidated earnings. Despite the segment's strong performance, limited financial disclosures raise concerns among investors. On the investment side, Markel's public equity portfolio, managed by CEO Tom Gayner, grew to $11.8 billion by 2024 and includes high-quality names like Berkshire Hathaway. However, it has underperformed broader market indices by 100–150 basis points over 5–10 years. With $13.1 billion in net cash and investments—or $1,025 per share—this sum makes up over half of Markel's market cap, although not all of it is excess capital due to regulatory requirements. The stock's underperformance has caught the attention of activist investors, including JANA Partners, who have urged a separation of the insurance and Ventures businesses to unlock value. Markel's management has acknowledged areas needing improvement, particularly insurance, stating that improved results here are essential for the company's long-term potential. Capital allocation has shifted significantly in recent years. After spending $4.2 billion on acquisitions between 2015–2021, Markel deployed $8.8 billion into its investment portfolio since 2021. Share buybacks have also increased meaningfully, reaching $573 million in 2024—though still modest relative to its $23 billion market cap. Valuation remains a core topic. Markel uses a two-part intrinsic value estimate based on operating earnings and net asset value, applying a conservative 12x multiple to normalized earnings. As of year-end 2024, this approach yielded an intrinsic value of $2,610 per share, up 18% CAGR over five years, versus just a 9% CAGR in stock price. Alternatively, with $1.94 billion in earnings and $13.1 billion in net investments, the stock trades at an implied 5.1x multiple, suggesting meaningful undervaluation. With operational tailwinds in Ventures, strategic pressure to unlock asset value, and visible capital deployment into buybacks, Markel presents a compelling investment opportunity with multiple levers for upside if execution improves—especially in insurance.
Cision Canada
07-05-2025
- Business
- Cision Canada
Markel launches Clinical Trials products to support clinical trials research, globally
LONDON, May 7, 2025 /CNW/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE: MKL), today announced the launch of its Clinical Trials insurance product – underscoring its commitment to providing best-in-class solutions to support clinical trials research and product development on an international scale. The new clinical trials offering provides comprehensive cover to sponsors, researchers and participants throughout all phases of clinical research and is tailored to meet the regulatory requirements of more than 100 territories, ensuring smooth and compliant trial operations, worldwide. As part of its service offering, Markel can offer same-day turnaround for quotations, as well as the issuance of certificates and policy documents through its automated document production platform, so that clinical trial sponsors and researchers can get the required insurance in place to begin clinical trials in a timely manner and meet regulatory deadlines. Markel utilises its Lloyd's licenses and extensive global network to provide these solutions to ensure a compliant solution where required. "Clinical trials insurance is a regulatory requirement in many countries and it's often the last hurdle to get approval to begin clinical research," says Robert Hannaford, Senior Underwriter – Life Science, Markel. "Delays to this process can result in sizeable costs, reputational damage and suspend vital research from going ahead for sponsors and researchers. "At Markel, we understand the time-sensitive nature of these requests and have developed a compliant solution – backed by our expert underwriting and award-winning claims service, making sure clients are fully protected to carry out the clinical research of products worldwide." Hannaford continues: "We do not want insurance to be a delaying factor to allowing important clinical research to begin, which is why we've produced a customer-centric product that streamlines all parts of the insurance value chain to prioritise service. "We look forward to supporting innovation in the life science industry by continuing to deliver effective risk transfer solutions for future lifesaving treatments through open communication, dialogue and transparency with our brokers, insureds and trading partners." About Markel Insurance We are Markel Insurance, a leading global specialty insurer with a truly people-first approach. As the insurance operations within the Markel Group Inc. (NYSE: MKL), we leverage a broad array of capabilities and expertise to create intelligent solutions for the most complex specialty insurance needs. However, it is our people – and the deep, valued relationships they develop with colleagues, brokers and clients – that differentiates us worldwide.
Washington Post
01-05-2025
- Business
- Washington Post
Markel Group: Q1 Earnings Snapshot
GLEN ALLEN, Va. — GLEN ALLEN, Va. — Markel Group Inc. (MKL) on Wednesday reported first-quarter earnings of $121.7 million. The Glen Allen, Virginia-based company said it had net income of $12.08 per share. Earnings, adjusted for non-recurring costs, came to $25.72 per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $18.89 per share.
